Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Troriluzole in Adult Participants With Spinocerebellar Ataxia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for troriluzole in adults with spinocerebellar ataxia; results were posted on 2025-02-10 and the study is currently ACTIVE_NOT_REC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Troriluzole (troriluzole)

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-10